Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada
Clinical trial NCT06361563 · COMPLETED
Trial details
- NCT number
- NCT06361563
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-05
- Primary completion
- 2024-01-25
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.